Top 50 Pharmaceutical Companies 2014

Who are the top pharmaceutical companies in the world and what are they worth in 2014?

The Pharmaceutical and Biotechnology continue to dominate the world’s R&D expenditure, with more companies in the top 10 than any other sector. This year, whilst Novartis has knocked Roche from their top spot, individual R&D spends by pharma and biotechs fail to compete with the likes of Volkswagen and Samsung who’s spends were around $11 billion in 2013. Between the top 50 BigPharma and biotech companies $85.7 billion was spend on R&D in 2013, which represents a decrease in spending of $2.8 billion compared to 2012.

The Top 50 Pharmaceutical Companies by Research and Development Investment:

Pharma Rank

World Rank

Company

Country

$million

1 5 NOVARTIS Switzerland 7173.5
2 6 ROCHE Switzerland 7076.2
3 8 JOHNSON & JOHNSON US 5933.6
4 12 MERCK US US 5165.0
5 14 SANOFI-AVENTIS France 4757.0
6 15 PFIZER US 4750.2
7 21 GLAXOSMITHKLINE UK 4154.3
8 23 ELI LILLY US 4010.8
9 34 BAYER Germany 3259.0
10 37 ASTRAZENECA UK 3202.8
11 38 AMGEN US 2960.6
12 39 BOEHRINGER INGELHEIM Germany 2743.0
13 40 BRISTOL-MYERS SQUIBB US 2705.4
14 45 TAKEDA PHARMACEUTICAL Japan 2352.0
15 52 ABBVIE US 2059.3
16 63 OTSUKA Japan 1714.7
17 65 CELGENE US 1603.4
18 66 NOVO NORDISK Denmark 1567.4
19 68 GILEAD SCIENCES US 1537.1
20 70 MERCK DE Germany 1504.3
21 77 ASTELLAS PHARMA Japan 1318.4
22 78 DAIICHI SANKYO Japan 1316.6
23 95 ABBOTT LABORATORIES US 1052.9
24 96 BIOGEN IDEC US 1047.1
25 100 TEVA PHARMACEUTICAL INDUSTRIES Israel 1031.1
26 124 EISAI Japan 898.9
27 125 SERVIER France 895.0
28 144 UCB Belgium 781.0
29 150 ALLERGAN US 754.7
30 165 SHIRE UK 645.5
31 193 VERTEX PHARMACEUTICALS US 508.3
32 215 ACTAVIS Ireland 447.3
33 263 SHIONOGI Japan 357.6
34 273 CSL Australia 338.2
35 278 ONO PHARMACEUTICAL Japan 334.5
36 282 MYLAN US 330.8
37 284 ACTELION Switzerland 329.6
38 296 HOSPIRA US 305.2
39 307 ZOETIS US 289.3
40 338 IPSEN France 267.6
41 347 BIOMARIN PHARMACEUTICAL US 257.3
42 356 FOREST LABORATORIES US 251.4
43 357 GRUNENTHAL Germany 250.9
44 365 BIOMERIEUX France 235.7
45 380 ALEXION PHARMACEUTICALS US 222.6
46 389 UNITED THERAPEUTICS US 217.1
47 400 H LUNDBECK Denmark 210.1
48 413 ILLUMINA US 200.7
49 417 CHIESI FARMACEUTICI Italy 198.0
50 446 NOVOZYMES Denmark 185.1

Source: European Commission, The 2014 EU Industrial R&D Investment Scoreboard 

Leave a Reply

Your email address will not be published. Required fields are marked *